Shiseido Q1
This article was originally published in The Rose Sheet
Executive Summary
Japanese cosmetics manufacturer initiates "proactive" management in Q1 (ended June 30), making "aggressive investments" to grow share in domestic cosmetics market and strengthen development in China, firm says in July 26 sales and earnings release. Shiseido's cosmetics sales were up 2.1% to $1.05 bil. (¥1=$.0091), while toiletries division sales fell 3.1% to $121 mil. Domestic sales fell a slight .5%, while overseas revenues grew 7.7%, driven by strong growth in China, firm says. Sales in the Americas grew 3.3% to $88 mil. in the quarter. Consolidated net sales grew 1.7% to $1.3 bil., while consolidated net loss was $60 mil., an improvement over the $76.6 mil. loss reported last year...
You may also be interested in...
EU Regulatory Assessors Get AI Boost In Reaching Scientific Decisions
The European Medicines Agency is training scientific staff working for the European medicines regulatory network in how to use a new AI-powered search engine that allows them to easily retrieve information on regulatory precedents.
EU Parliament Stricter Than Council On Medicines And Medical Devices Packaging
The EU Parliament's Environment, Public Health and Food Safety committee takes a compromise position with regards to the Packaging and Packaging Waste Directive. Medicines and medical devices should be exempt, but only until 2035, at which point the European Commission should check whether the development of materials and the recycling process have progressed, and may adjust this exemption accordingly.
Stay Or Exit? Global Health Players Ponder New China Trajectory
It's again the time of year when global CEOs descend on China's capital to discuss strategies. This year, however, the mood is different.